| Application no. and date | 17807296.3 (espacenet) (Federated) (European Patent Register), 20170526 | | Patent/reg. no. and date | DK/EP 3463315, 20230614 | | Publication date | 20190410 | | Priority no. and date | US 201662344878 P, 20160602, US 201662344870 P, 20160602 | | EP pub. no. and date |
EP 3463315 20190410 | | Effective date | | | Applicant/owner | ADS Therapeutics LLC, 15615 Alton Parkway, Suite 450
Irvine, CA 92618-3308, US | | Applicant ref. no. | | | Inventor | NI, Jinsong, 145 Cloudbreak
Irvine, California 92618, US,
YANG, Rong, 145 Cloudbreak
Irvine, California 92618, US | | Representative | | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 31/506 (2006.01) , A61K 9/00 (2006.01) , A61K 9/50 (2006.01) , A61P 27/06 (2006.01) , C07D 209/34 (2006.01) | | Title | COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION | | Int. application no. | US2017034795 | | Int. publication no. | WO2017210132 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
